Insider trade

Director received an award of 158.68 ZBH derivative securities

Traded Jun 30, 2026 · Filed Jul 2, 2026

Zimmer BiometZBH

158.68
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 30, 2026
Reporting period: Not applicable
Filed with the SEC: Jul 2, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001999146-26-000008
Filed / recorded

Jul 2, 2026, 8:20 PM UTC

Added to OQRO

Oct 2, 2026, 12:29 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

ZIMMER BIOMET HOLDINGS, INC.

Issuer CIK

1136869

Ticker

ZBH

Reporting person

Louis Shapiro

Relationship

Director

Security

Phantom Stock Units

Table

Derivative (Table II)

Transaction date

Jun 30, 2026

Transaction code

A

Shares / units

158.684

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

3,703.1

Ownership form

Direct

Amendment

No

Footnotes from the filing

The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
The Conversion or Exercise Price of Derivative Security is 1-for-1.
Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.